Junlin Yi
Overview
Explore the profile of Junlin Yi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
87
Citations
532
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ren W, Pan Z, Men K, Liang B, Xu Q, Yi J, et al.
BMC Med Imaging
. 2025 Mar;
25(1):74.
PMID: 40038595
Background: Considering the potential association between radiation-induced hypothyroidism (RHT) and the thyroid subregions as well as the received radiation dose in each subregion, this study aims to develop a subregional...
2.
Ma Y, Ma X, Li C, Jiang Y, Zhang Z, Xiao J, et al.
Radiother Oncol
. 2025 Feb;
205:110773.
PMID: 39914742
Background And Purpose: Magnetic resonance-guided adaptive radiotherapy (MRgART) may improve the efficacy of large brain metastases (BMs)(≥2 cm), whereas the workflow requires optimized. This study develops a two-stage, personalized deep...
3.
Xu Y, Li C, Yin H, Nowsheen S, Xu X, Kang W, et al.
Nucleic Acids Res
. 2024 Nov;
52(22):13881-13895.
PMID: 39588777
The phosphorylation of histone H2A.X into γH2A.X is a crucial early event in the DNA damage response, marking DNA damage sites and initiating repair processes. While ATM kinase is traditionally...
4.
Liu Y, Yan W, Qi X, Zhang Y, Wang K, Qu Y, et al.
Cancer Lett
. 2024 Sep;
605:217276.
PMID: 39349290
Dynamic therapy response is strongly associated with cancer outcomes. This study aimed to evaluate the significance of longitudinal Epstein-Barr virus (EBV) DNA and radiological tumor regression in risk stratification and...
5.
Liu Y, Liu X, Sun S, Han Y, Feng M, Zhang Y, et al.
Lancet Reg Health West Pac
. 2024 Aug;
49:101147.
PMID: 39149139
Background: The survival rates of patients with nasopharyngeal carcinoma (NPC) have improved significantly, but there is no consensus on whether they can be considered cured. We aimed to determine whether...
6.
Li S, Amakye W, Zhao Z, Xin X, Jia Y, Zhang H, et al.
Nutrition
. 2024 Aug;
126:112520.
PMID: 39111096
Body weight, body mass index (BMI), Nutrition Risk Screening 2002 (NRS2002), and prognostic nutritional index (PNI) are among vital nutrition status indices employed during cancer treatment. These have also been...
7.
Liu Y, Sun S, Zhang Y, Huang X, Wang K, Qu Y, et al.
J Natl Cancer Cent
. 2024 Jul;
3(4):295-305.
PMID: 39036668
Objective: Accurate prognostic predictions and personalized decision-making on induction chemotherapy (IC) for individuals with locally advanced nasopharyngeal carcinoma (LA-NPC) remain challenging. This research examined the predictive function of tumor burden-incorporated...
8.
Zhou F, Liu L, Huang X, Sun S, Chen X, Chen Q, et al.
J Natl Cancer Cent
. 2024 Jul;
2(1):60-67.
PMID: 39035214
Objective: This study aimed to evaluate the prognostic value of the pretreatment systemic immune-inflammation index (SII) in non-metastatic nasopharyngeal carcinoma (NPC). Methods: We retrospectively analyzed the data of 839 patients...
9.
Wang J, Moon J, Guo X, Yu J, Yi J, Bae S
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001437
Background: Because of the rarity, heterogeneous histology, and diverse anatomical sites of salivary gland cancer (SGC), there are a limited number of clinical studies on its management. This study reports...
10.
Zhang P, Zhang X, Lang J, Wu S, Sun Y, Wang P, et al.
MedComm (2020)
. 2024 Jul;
5(7):e608.
PMID: 38962426
Patients with locally advanced head and neck squamous cell carcinoma (LA-HNSCC) have poor survival outcomes. The real-world efficacy of nimotuzumab plus intensity modulated radiotherapy (IMRT)-based chemoradiotherapy in patients with LA-HNSCC...